The p53 Network*
暂无分享,去创建一个
M L Agarwal | W R Taylor | M V Chernov | O B Chernova | G R Stark | G. Stark | M. V. Chernov | W. Taylor | M. Agarwal | O. Chernova
[1] O. Halevy,et al. Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53 , 1990, Cell.
[2] R. DePinho,et al. p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens , 1994, Nature.
[3] J. Shay,et al. Inhibition of Protein Phosphatase Activity Induces p53-dependent Apoptosis in the Absence of p53 Transactivation* , 1997, The Journal of Biological Chemistry.
[4] G. Stein,et al. Cell cycle independent interaction of CDC2 with the centrosome, which is associated with the nuclear matrix-intermediate filament scaffold. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[5] T. Soussi,et al. p53-dependent pathway of radio-induced apoptosis is altered in Fanconi anemia. , 1995, Oncogene.
[6] Thea D. Tlsty,et al. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53 , 1992, Cell.
[7] G. Wahl,et al. p53-dependent cell cycle arrests are preserved in DNA-activated protein kinase-deficient mouse fibroblasts. , 1996, Cancer research.
[8] G. Stark,et al. p53-dependent growth arrest of REF52 cells containing newly amplified DNA. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[9] E. Wagner,et al. Defective induction but normal activation and function of p53 in mouse cells lacking poly-ADP-ribose polymerase , 1997, Oncogene.
[10] A. Yang,et al. Monoallelically Expressed Gene Related to p53 at 1p36, a Region Frequently Deleted in Neuroblastoma and Other Human Cancers , 1997, Cell.
[11] W. B. Smith,et al. A Role for Endothelial NO Synthase in LTP Revealed by Adenovirus-Mediated Inhibition and Rescue , 1996, Science.
[12] E. White,et al. Bcl-2 blocks p53-dependent apoptosis , 1994, Molecular and cellular biology.
[13] M. Lohrum,et al. Differential effects of phosphorylation of rat p53 on transactivation of promoters derived from different p53 responsive genes. , 1996, Oncogene.
[14] W. Jongmans,et al. Nijmegen breakage syndrome cells fail to induce the p53-mediated DNA damage response following exposure to ionizing radiation , 1997, Molecular and cellular biology.
[15] B. Vogelstein,et al. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia , 1992, Cell.
[16] G. Wahl,et al. Sensitivity and selectivity of the DNA damage sensor responsible for activating p53-dependent G1 arrest. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[17] W. Kaelin,et al. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[18] G. Stark,et al. The p53 activation and apoptosis induced by DNA damage are reversibly inhibited by salicylate , 1997, Oncogene.
[19] L. Old,et al. Microinjection of monoclonal antibody to protein p53 inhibits serum-induced DNA synthesis in 3T3 cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[20] E. White,et al. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. , 1993, Genes & development.
[21] C. Whitacre,et al. Involvement of NAD-poly(ADP-ribose) metabolism in p53 regulation and its consequences. , 1995, Cancer research.
[22] M. Karin,et al. p53-Dependent apoptosis in the absence of transcriptional activation of p53-target genes , 1994, Nature.
[23] D. Lane,et al. Small peptides activate the latent sequence-specific DNA binding function of p53 , 1995, Cell.
[24] B. Vogelstein,et al. Participation of p53 protein in the cellular response to DNA damage. , 1991, Cancer research.
[25] A. Jochemsen,et al. Bloom's syndrome cells GM1492 lack detectable p53 protein but exhibit normal G1 cell-cycle arrest after UV irradiation. , 1994, Oncogene.
[26] A. Levine,et al. p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts. , 1991, Genes & development.
[27] C. Purdie,et al. Thymocyte apoptosis induced by p53-dependent and independent pathways , 1993, Nature.
[28] G. Wahl,et al. A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. , 1996, Genes & development.
[29] K. Kinzler,et al. Genetic determinants of p53-induced apoptosis and growth arrest. , 1996, Genes & development.
[30] G. V. Vande Woude,et al. Synergy between the Mos/mitogen-activated protein kinase pathway and loss of p53 function in transformation and chromosome instability , 1997, Molecular and cellular biology.
[31] J. Ferrell,et al. A Role for Mitogen-activated Protein Kinase in the Spindle Assembly Checkpoint in XTC Cells , 1997, The Journal of cell biology.
[32] G. Hicks,et al. Evidence for a second cell cycle block at G2/M by p53. , 1995, Oncogene.
[33] G. Zambetti,et al. Inhibition of DNA topoisomerase II alpha gene expression by the p53 tumor suppressor , 1997, Molecular and cellular biology.
[34] C. Prives,et al. Increased and altered DNA binding of human p53 by S and G2/M but not Gl cyclin-dependent kinases , 1995, Nature.
[35] S. Lowe,et al. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. , 1993, Genes & development.
[36] G. Stark,et al. The role of p53 in regulating genomic stability when DNA and RNA synthesis are inhibited. , 1995, Trends in biochemical sciences.
[37] F. Toledo,et al. Expression of Fragile Sites Triggers Intrachromosomal Mammalian Gene Amplification and Sets Boundaries to Early Amplicons , 1997, Cell.
[38] G. Wahl,et al. DNA rereplication in the presence of mitotic spindle inhibitors in human and mouse fibroblasts lacking either p53 or pRb function. , 1997, Cancer research.
[39] A. Kimchi,et al. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6 , 1991, Nature.
[40] C. Thompson,et al. Expression of Bcl-xL and loss of p53 can cooperate to overcome a cell cycle checkpoint induced by mitotic spindle damage. , 1996, Genes & development.
[41] E. White,et al. Both viral (adenovirus E1B) and cellular (hsp 70, p53) components interact with centrosomes , 1994, Journal of cellular physiology.
[42] F. Watt,et al. DNA amplification is rare in normal human cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[43] G. Stark,et al. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[44] M. Fiscella,et al. Mutation of the serine 15 phosphorylation site of human p53 reduces the ability of p53 to inhibit cell cycle progression. , 1993, Oncogene.
[45] M. Kubbutat,et al. Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability , 1997, Molecular and cellular biology.
[46] G. Wahl,et al. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles , 1992, Cell.
[47] E. Stanbridge,et al. DNA damage and p53-mediated cell cycle arrest: a reevaluation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[48] P. Howley,et al. Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation , 1997, Molecular and cellular biology.
[49] G. Stark,et al. Multiple mechanisms of N-phosphonacetyl-L-aspartate resistance in human cell lines: carbamyl-P synthetase/aspartate transcarbamylase/dihydro-orotase gene amplification is frequent only when chromosome 2 is rearranged. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[50] E. Wagner,et al. Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease. , 1995, Genes & development.
[51] X. Chen,et al. p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. , 1996, Genes & development.
[52] M. Oren,et al. Mdm2 promotes the rapid degradation of p53 , 1997, Nature.
[53] W. Deppert,et al. Negative feedback regulation of wild‐type p53 biosynthesis. , 1995 .
[54] D. Meek,et al. Phosphorylation of the tumor suppressor protein p53 by mitogen-activated protein kinases. , 1994, The Journal of biological chemistry.
[55] S. Jackson,et al. The DNA-dependent protein kinase: Requirement for DNA ends and association with Ku antigen , 1993, Cell.
[56] Stephen N. Jones,et al. Regulation of p53 stability by Mdm2 , 1997, Nature.
[57] G. Stark,et al. Simian virus 40 large tumor antigen alone or two cooperating oncogenes convert REF52 cells to a state permissive for gene amplification. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[58] S. Friend,et al. Strange bedfellows in even stranger places: the role of ATM in meiotic cells, lymphocytes, tumors, and its functional links to p53. , 1996, Genes & development.
[59] J. Little,et al. Relationship between radiation-induced G1 phase arrest and p53 function in human tumor cells. , 1995, Cancer research.
[60] B. Vogelstein. A deadly inheritance , 1990, Nature.
[61] W. Maltzman,et al. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells , 1984, Molecular and cellular biology.
[62] Wei Gu,et al. Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain , 1997, Cell.
[63] E. Shaulian,et al. Induction of apoptosis in HeLa cells by trans-activation-deficient p53. , 1995, Genes & development.
[64] G R Stark,et al. Regulation and mechanisms of mammalian gene amplification. , 1993, Advances in cancer research.
[65] K. Sakaguchi,et al. Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53 , 1992, Molecular and cellular biology.
[66] A. Levine. p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.
[67] G. Stark,et al. MYC Abrogates p53-Mediated Cell Cycle Arrest in N-(Phosphonacetyl)-l-Aspartate-Treated Cells, Permitting CAD Gene Amplification , 1998, Molecular and Cellular Biology.
[68] N. Hay,et al. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. , 1994, Genes & development.
[69] G. Wahl,et al. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. , 1994, Genes & development.
[70] S. Lowe,et al. Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a , 1997, Cell.
[71] Stephen J. Elledge,et al. Mice Lacking p21 CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control , 1995, Cell.
[72] C. Prives,et al. p53: puzzle and paradigm. , 1996, Genes & development.
[73] Carissa A. Sanchez,et al. A p53-dependent mouse spindle checkpoint , 1995, Science.
[74] Xin Lu,et al. Differential induction of transcriptionally active p53 following UV or lonizing radiation: Defects in chromosome instability syndromes? , 1993, Cell.